Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine

J Cell Mol Med. 2016 Dec;20(12):2410-2413. doi: 10.1111/jcmm.12912. Epub 2016 Jul 29.

Authors

Zheyong Huang¹, Yanan Song¹, Zhiqing Pang², Minghui Li¹, Yerkintay Guliya¹, Yunli Shen³, Juying Qian¹, Junbo Ge¹

Affiliations

¹ Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
² School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai, China.
³ Department of Cardiology, Shanghai East Hospital, Tongji University, Shanghai, China.

No abstract available

Keywords: CREKA; cell therapy; fibrin; myocardial infarction; targeting therapy.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Drug Delivery Systems / methods
Fibrin / antagonists & inhibitors
Fibrin / metabolism*
Humans
Molecular Targeted Therapy / methods
Myocardial Infarction / metabolism
Myocardial Infarction / therapy*
Oligopeptides / administration & dosage
Oligopeptides / metabolism*
Oligopeptides / pharmacology
Protein Binding
Rats
Regenerative Medicine / methods
Stem Cell Transplantation / methods*
Stem Cells / metabolism*

Substances

Oligopeptides
cysteinyl-arginyl-glutamyl-lysyl-alanyl
Fibrin